Search

Objective: To determine the prevalence of work-related musculoskeletal disorders among dentists., Methods: The cross-sectional study was conducted in Islamabad, Pakistan, from January to March 2023 after approval from the ethics review committee of the Islamic International Dental Hospital, Islamabad, and comprised dentists associated with 4 major dental teaching hospitals in the city. Data was collected using a self-administered questionnaire adapted from literature. Prevalence of work-related musculoskeletal disorders was explored along with its association with variables, like age, gender, experience, designation and history of injury. Data was analysed using SPSS 26., Results: Of the 250 forms distributed, 188 (75.2%) were returned duly filled, while the remaining participants either did not respond or partially filled out the forms. Among the respondents, 64(34%) were males and 124(66%) were females, and the overall prevalence of work-related musculoskeletal disorders was 172(91.5%). There was no significant difference among the variables based on anatomic site-specific data, except the designation variable, with individuals having a history of injury to neck (p=0.027) or shoulder (p=0.001) and those designated as professor (p=0.040) were significantly at risk of developing pain due to work-related musculoskeletal disorders., Conclusions: A significantly high number of dentists were found to have some form of work-related musculoskeletal disorder.

Objective: This article critically reviews the recent search on the use of Small Interfering RNA (siRNA) in the process of gene regulation that has been harnessed to silence specific genes in various cell types, including those involved in diabetes complications., Significance: Diabetes, a prevalent and severe condition, poses life-threatening risks due to elevated blood glucose levels. It results from inadequate insulin production by the pancreas or ineffective insulin utilization by the body. Recent research suggests siRNA could hold promise in addressing diabetes complications., Methods: In this review, we discussed several subjects, including diabetes; its function, and common treatment options. An in-depth analysis of gene silencing method for siRNA and role of siRNA in diabetes, focusing on its impact on glucose homeostasis, diabetic retinopathy, wound healing, diabetic nephropathy and peripheral neuropathy, diabetic foot ulcers, diabetic atherosclerosis, and diabetic cardiomyopathy., Result: siRNA-based treatment has the potential to target specific genes without disrupting several other endogenous pathways, which decreases the risk of off-target effects. In addition, siRNA has the capability to provide long-term efficacy with a single dose which will reduce treatment options and enhance patient compliance., Conclusion: In the context of diabetic complications, siRNA has been explored as a potential therapeutic tool to modulate the expression of genes involved in various processes associated with diabetes-related issues such as Diabetic Retinopathy, Neuropathy, Nephropathy, wound healing. The use of siRNA in these contexts is still largely experimental, and challenges such as delivery to specific tissues, potential off-target effects, and long-term safety need to be addressed. Additionally, the development of siRNA-based therapies for clinical use in diabetic complications is an active area of research., Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-024-01405-7., Competing Interests: Competing interestsThe authors declared no financial interest., (© The Author(s), under exclusive licence to Tehran University of Medical Sciences 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)

The current study investigates the potential for topical delivery of a fluticasone propionate (FP) and levocetirizine dihydrochloride (CTZ)-loaded microemulsion (ME) for the management of atopic dermatitis. Various microemulsion components were chosen based on their solubility and emulsification capabilities, and the ternary phase diagram was constructed. A total of 12 microemulsion formulations were screened for various attributes like vesicle size, polydispersity index, ζ-potential, percent transmittance, density, and pH. The average globule size and ζ-potential of FP and levocetirizine-containing ME were 52.12 nm and -2.98 ζ-potential, respectively. Transmission electron microscopy confirmed the spherical nature of the globules. The developed system not only controlled the release of both drugs but also enhanced the efficacy of the drugs on a rodent model. Histopathological studies confirmed the safety of the developed system. The present findings provide evidence for a scalable and simpler approach for the management of atopic dermatitis., Competing Interests: The authors declare no competing financial interest., (© 2022 The Authors. Published by American Chemical Society.)